Cluster of hemolytic-uremic syndrome caused by Shiga toxin-producing Escherichia coli O26:H11

Pediatric Infectious Disease Journal

Volumn 22, Issue 4, 2003, Pages 349-354

  Misselwitz, Joachim ^a,c   Karch, Helge ^b   Bielazewska, Martina ^b   John, Ulrike ^a   Ringelmann, Felix ^a   Rönnefarth, Gabriele ^a   Patzer, Ludwig ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c Children's Hospital of University   (Germany)

Author keywords

Cluster; Escherichia coli O26:H11; Hemolyticuremic syndrome; Shiga toxin

Indexed keywords

ANTIHYPERTENSIVE AGENT; CEFOTAXIME; IMMUNOGLOBULIN; SHIGA TOXIN; VANCOMYCIN;

ANTIBIOTIC THERAPY; ANURIA; ARTICLE; BACTERIAL GENETICS; BACTERIAL STRAIN; BACTERIUM ISOLATION; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DISEASE SEVERITY; ECHOGRAPHY; EPIDEMIC; ERYTHROCYTE TRANSFUSION; ESCHERICHIA COLI; EUROPE; FECES ANALYSIS; FEMALE; HEMODIALYSIS; HEMOLYTIC ANEMIA; HEMOLYTIC UREMIC SYNDROME; HUMAN; HYPERTENSION; LABORATORY TEST; MALE; MICROBIOLOGICAL EXAMINATION; MOLECULAR DYNAMICS; NONHUMAN; PERITONEAL DIALYSIS; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; SEROLOGY; SEROTYPE; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

CLUSTER ANALYSIS; DISEASE OUTBREAKS; ESCHERICHIA COLI O157; FECES; FEMALE; GENES, BACTERIAL; GERMANY; HEMOLYTIC-UREMIC SYNDROME; HUMANS; IMMUNOMAGNETIC SEPARATION; INCIDENCE; INFANT; MALE; RISK ASSESSMENT; SAMPLING STUDIES; SEROLOGIC TESTS; SEVERITY OF ILLNESS INDEX; SHIGA TOXIN;

EID: 0345373923     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200304000-00012     Document Type: Article

References (40)

1. Pistor K, Bunka M. Akutes Nierenversagen im Kindesalter. Kinder-Jugendarzt 2000;12:1106-11.
2. Banatvala N, Griffin PM, Greene KD, et al. The United States National Prospective Study: microbiological, serologic, clinical, and epidemiological findings. J Infect Dis 2001;183:1063-70.
3. Brandt JR, Joseph MW, Fouser LS, et al. Cholelithiasis following Escherichia coli O157:H7-associated hemolytic uremic syndrome. Pediatr Nephrol 1998;12:222-5.
4. Siegler RL. The hemolytic uremic syndrome. Pediatr Clin North Am 1995;42:1505-29.
5. Karmali, MA, Steele BT, Petric M, Lim C. Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools. Lancet 1983;1:619-20.
6. Karmali MA, Petric M, Lim C, Fleming PC, Arbus GS, Lior H. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis 1985;151:775-82.
7. Riley LW, Remis RS, Helgerson SD, et al. Hemorrhagic colitis associated with a rare Escherichia coli serotype. N Engl J Med 1983;308:681-5.
8. Karch H, Bielaszewska M, Bitzan M, Schmidt H. Epidemiology and diagnosis of Shiga toxin-producing Escherichia coli infections. Diagn Microbiol Infect Dis 1999;34:229-43.
9. Mead PS, Griffin PM. Escherichia coli O157:H7. Lancet 1998;352:1207-12.
10. Griffin PM. Epidemiology of Shiga toxin-producing Escherichia coli infections in humans in the United States. In: Kaper JB, O'Brien AD, eds. Escherichia coli O157:H7 and other Shiga toxin-producing E. coli strains. Washington, DC: American Society for Microbiology, 1998:15-22.
11. Michino H, Araki H, Minami S, et al. Recent outbreaks of infections caused by Escherichia coli O157:H7 in Japan. In: Kaper JB, O'Brien AD, eds. Escherichia coli O157:H7 and other Shiga toxin-producing E. coli strains. Washington, DC: American Society for Microbiology, 1998:73-81.
12. Smith, HR, Rowe B, Adak GK, Reilly WJ. Shiga toxin (verocytotoxin)-producing Escherichia coli in the United Kingdom. In: Kaper JB, O'Brien AD, eds. Escherichia coli O157:H7 and other Shiga toxin-producing E. coli strains. Washington, DC: American Society for Microbiology, 1998:49-58.
13. Bielaszewska M, Karch H. Non-O157:H7 Shiga toxin (verocytotoxin)-producing Escherichia coli strains: epidemiological significance and microbiological diagnosis. World J Microbiol Biotechnol 2000;16:711-18.
14. Bockemühl J, Karch H, Tschäpe H. Infektionen des Menschen durch enterohämorrhagische Escherichia coli (EHEC) in Deutschland, 1996. Bundesgesundhbl 1997;6:194-197.
15. Bockemühl, J, Karch H, Tschäpe H. Zur Situation der Infektionen des Menschen durch enterohämorrhagische Escherichia coli (EHEC) in Deutschland, 1997. Bundesgesundhbl 1998;Suppl (October):2-5.
16. Verweyen HM, Karch H, Allerberger F, Zimmerhackl LB. Enterohemorrhagic Escherichia coli (EHEC) in pediatric hemolytic-uremic syndrome: a prospective study in Germany and Austria. Infection 1999;27:341-7.
17. Sramkova L, Bielaszewska M, Janda J, Blahova K, Hausner O. Verocytotoxin-producing strains of Escherichia coli in children with haemolytic uraemic syndrome and diarrhoea in Czechoslovakia. Infection 1990;18:204-9.
18. Bielaszewska M, Janda J, Blahova K, Feber J, Potuznik V, Souckova A. Verocytotoxin-producing Escherichia coli in children with hemolytic uremic syndrome in the Czech Republic. Clin Nephrol 1996;46:42-4.
19. Kudoh Y, Kai A, Obata H, et al. Epidemiological surveys on verocytotoxin-producing Escherichia coli in Japan. In: Karmali MA, Goglio AG, eds. Recent advances in verocytotoxin-producing Escherichia coli infections. In: Proceedings of the Second International Symposium and Workshop on Verocytotoxin (Shiga-like toxin)-producing Escherichia coli Infections, Bergamo, Italy, June 27 to 30, 1994. Amsterdam: Elsevier, 1994:53-6.
20. Banatvala N, Debeukelaer MM, Griffin PM, et al. Shiga-like toxin-producing Escherichia coli O111 and associated hemolytic-uremic sydrome: a family outbreak. Pediatr Infect Dis J 1996;15:1008-11.
21. Paton AW, Ratcliff RM, Doyle RM, et al. Molecular microbiological investigation of an outbreak of hemolytic-uremic syndrome caused by dry fermented sausage contaminated with Shiga-like toxin-producin Escherichia coli. J Clin Microbiol 1996;34:1622-7.
22. Caprioli A, Luzzi I, Rosmini F, et al. Community-wide outbreak of hemolytic-uremic syndrome associated with non-O157 verocytotoxin-producing Escherichia coli. J Infect Dis 1994;169:208-211.
23. Karch H, Huppertz HI, Bockemiihl J, Schmidt H, Schwarzkopf A, Lissner R. Shiga toxin-producing Escherichia coli infections in Germany. J Food Prot 1997;11:1454-7.
24. Schmidt H, Riissmann H, Schwarzkopf A, Aleksic S, Heesemann J, Karch H. Prevalence of attaching and effacing Escherichia coli in stool samples from patients and controls. Zentralbl Bakteriol 1994;281:201-13.
25. Cebula TA, Payne WL, Feng P. Simultaneous identification of strains of Escherichia coli serotype O157:H7 and their Shiga-like toxin type by mismatch amplification mutation assay-multiplex PCR. J Clin Microbiol 1995;33:248-50.
26. Schmidt H, Beutin L, Karch H. Molecular analysis of the plasmid-encoded hemolysin of Escherichia coli O157:H7 strain EDL 933. Infect Immun 1995;63:1055-61.
27. Oswald E, Schmidt H, Morabito S, Karch H, Marches O, Caprioli A. Typing of intimin genes in human and animal enterohemorrhagic and enteropathogenic Escherichia coli: characterization of a new intimin variant. Infect Immun 2000;68:64-71.
28. Schmidt H, Henkel, B, Karch H. A gene cluster closely related to type II secretion pathway operons of Gram-negative bacteria is located on the large plasmid of enterohaemorrhagic Escherichia coli O157 strains. FEMS Microbiol Lett 1997;148:265-72.
29. Brunder W, Schmidt H, Karch H. KatP, a novel catalaseperoxidase encoded by the large plasmid of enterohaemorrhagic Escherichia coli O157:H7. Microbiology 1996;142:3305-15.
30. Brunder W, Schmidt H, Karch H. EspP, a novel extracellular serine protease of enterohaemorrhagic Escherichia coli O157:H7 cleaves human coagulation factor V. Mol Microbiol 1997;24:767-78.
31. PulseNet, standardized molecular subtyping of foodborne bacterial pathogens by pulsed-field gel electrophoresis. Atlanta: Centers for Disease Control and Prevention, 1998.
32. Bitzan M, Karch H. Indirect hemagglutination assay for diagnosis of Escherichia coli O157 infection in patients with hemolytic-uremic syndrome. J Clin Microbiol 1992;30:1174-8.
33. Hashimoto H, Mizukoshi K, Nishi M, et al. Epidemic of gastrointestinal tract infection including hemorrhagic colitic attributable to Shiga toxin 1-producing Escherichia coli O118:H2 at a junior high school in Japan. Pediatrics 1999;103:e2.
34. Moore K, Damrow T, Abbott DO, Jankowski S. Outbreak of acute gastroenteritis attributable to Escherichia coli serotype O104:H21: Helena, Montana, 1994. MMWR 1997;44:501-3.
35. Boudaillez B, Berquin P, Mariani-Kurkdjian P, et al. Possible person-to-person transmission of Escherichia coli 0111-associated hemolytic uremic syndrome. Pediatr Nephrol 1997;11:36-9.
36. +. Alimentaria 1996;275:109-13.
37. Hiruta N, Murase T, Okamura N. An outbreak of diarrhoea due to multiple antimicrobial-resistant Shiga toxin-producing Escherichia coli O26:H11 in a nursery. Epidemiol Infect 2000;127:221-7.
38. McMaster C, Roch EA, Willshaw GA, Doherty A, Kinnear W, Cheasty T. Verocytotoxin-producing Escherichia coli serotype O26:H11 outbreak in an Irish crèche. Eur J Clin Microbiol Infect Dis 2001;20:430-2.
39. Eklund M, Scheutz F, Siitonen A. Clinical isolates of non-O157 Shiga toxin-producing Escherichia coli: serotypes, virulence characteristics, and molecular profiles of strains of the same serotype. J Clin Microbiol 2000;39:2829-34.
40. Zhang W, Bielaszewska M, Liesegang A, et al. Molecular characteristics and epidemiological significance of Shiga toxin-producing Escherichia coli 026 strains. J Clin Microbiol 2000;38:2134-40.